Literature DB >> 18076733

Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus.

Joel H Rubenstein1, Sameer D Saini, Latoya Kuhn, Laurence McMahon, Pratima Sharma, Darrell S Pardi, Philip Schoenfeld.   

Abstract

BACKGROUND: Gastroenterologists' approach to surveillance for Barrett's esophagus is variable. We hypothesized that financial incentives and concerns over malpractice litigation influence gastroenterologists' usual practices regarding screening and surveillance.
METHODS: We surveyed gastroenterologists (N = 224) regarding their usual practice of screening or surveillance for Barrett's esophagus, belief in the efficacy of screening, knowledge of published guidelines, demographic factors, compensation structure, volume of endoscopies, and malpractice history. Practices were characterized as aggressive or conservative in the utilization of services compared with a published guideline.
RESULTS: Twenty-one percent of attending gastroenterologists reported being identified as a defendant in at least one malpractice suit. Prior malpractice defendants had practiced gastroenterology longer and performed a higher volume of endoscopies, but had similar knowledge regarding published screening guidelines to those who had not been defendants. They were more likely to be aggressive rather than conservative in screening and surveillance for Barrett's esophagus (odds ratio [OR] 3.6, 95% confidence interval [CI] 1.1-12), and remained so after controlling for other factors. In particular, they were more likely to recommend screening for populations with a lower risk of development of cancer, and to perform more frequent surveillance for low-grade dysplasia. Other factors were not associated with aggressive practice, including compensation structure.
CONCLUSIONS: History of at least one prior malpractice suit appears to be associated with the more aggressive use of endoscopic screening and surveillance for Barrett's esophagus, irrespective of physician belief regarding the efficacy of that strategy in reducing mortality. Hypervigilance and fear of future malpractice suits may drive this increased use.

Entities:  

Mesh:

Year:  2007        PMID: 18076733     DOI: 10.1111/j.1572-0241.2007.01689.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

1.  Barrett esophagus and life expectancy: implications for screening?

Authors:  Ernst J Kuipers
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

2.  Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists.

Authors:  Pratima Sharma; Sameer D Saini; Latoya B Kuhn; Joel H Rubenstein; Darrell S Pardi; Jorge A Marrero; Philip S Schoenfeld
Journal:  Dig Dis Sci       Date:  2010-10-27       Impact factor: 3.199

3.  Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium.

Authors:  Weitian Liu; Hejin Hahn; Robert D Odze; Raj K Goyal
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

4.  Surveillance in Barrett's esophagus: an audit of practice.

Authors:  Adewale Ajumobi; Khaled Bahjri; Christian Jackson; Ronald Griffin
Journal:  Dig Dis Sci       Date:  2009-08-11       Impact factor: 3.199

Review 5.  American Gastroenterological Association technical review on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

6.  Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study.

Authors:  Seth D Crockett; Isaac M Lipkus; Stephanie D Bright; Richard E Sampliner; Kenneth K Wang; Vikram Boolchand; Lori S Lutzke; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2011-11-17       Impact factor: 9.427

7.  Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.

Authors:  Joel H Rubenstein; James M Scheiman; Shahram Sadeghi; David Whiteman; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2010-12-07       Impact factor: 10.864

8.  A 52-year-old man with heartburn: should he undergo screening for Barrett's esophagus?

Authors:  Seth D Crockett; A Sidney Barritt; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2009-12-03       Impact factor: 11.382

Review 9.  Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance.

Authors:  Subhash Chandra; Emmanuel C Gorospe; Cadman L Leggett; Kenneth K Wang
Journal:  Curr Gastroenterol Rep       Date:  2013-05

10.  Surveillance in Barrett's esophagus: lessons from behavioral economics.

Authors:  Hashem B El-Serag; Aanand D Naik
Journal:  Gastroenterology       Date:  2009-07-28       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.